Lipoprotein autoantibodies: measurement and significance
- PMID: 12853376
- PMCID: PMC164259
- DOI: 10.1128/cdli.10.4.499-505.2003
Lipoprotein autoantibodies: measurement and significance
References
-
- Atchley, D. H., M. F. Lopes-Virella, D. Zheng, and G. Virella. 2002. Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy. Diabetologia 45:1562-1571. - PubMed
-
- Bellomo, G., E. Maggi, M. Poli, F. G. Agosta, P. Bollati, and G. Finardi. 1995. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes 44:60-66. - PubMed
-
- Binder, C. J., M. K. Chang, P. X. Shaw, Y. E. Miller, K. Hartvigsen, A. Dewan, and J. L. Witztum. 2002. Innate and acquired immunity in atherogenesis. Nat. Med. 8:1218-1226. - PubMed
-
- Boullier, A., M. Hamon, E. Walters-Laporte, F. Martin-Nizart, R. Mackereel, J. C. Fruchart, M. Bertrand, and P. Duriez. 1995. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease. Clin. Chim. Acta 238:1-10. - PubMed
-
- Boullier, A., E. Walters-Laporte, M. Hamon, A. Tailleux, C. Amant, P. Amouyel, J. Fruchart, M. Bertrand, and P. Duriez. 2000. Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty. Clin. Chim. Acta 299:129-140. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
